Joanna Boinska

Mrs. Joanna Boinska


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Qatar Medical Journal
Verified
Journal Article
Open access
EKEwelina Kolan′Ska-Dams
Ewelina Kolan′Ska-Dams
JBJoanna Boinska
Joanna Boinska
Maciej W. SochaMaciej W. Socha
Maciej W. Socha
Introduction: Central obesity appears to play a major role in the pathogenesis of metabolic disorders in polycystic ovary syndrome. Insulin resistance and carbohydrate disorders are associated with dysfunctional secretion of various adipokines by the adipose tissue. Objectives: This study aimed to evaluate leptin, apelin, and visfatin against a background of carbohydrate metabolism parameters in patients diagnosed de novo with polycystic ovary syndrome (PCOS). Material and methods: The study group consisted of 40 patients with PCOS (mean age, 29 years) diagnosed in accordance with the American Society for Reproductive Medicine criteria from 2003. The control group consisted of 37 clinically healthy women (mean age, 26 years). All controls had regular menses and no clinical or biochemical signs of hyperandrogenism. Concentrations of leptin, apelin, visfatin, and insulin were measured by immunoenzymatic methods. Glucose concentrations were determined using spectrophotometry. Results: Significantly higher concentrations of leptin, insulin, homeostatic model assessment for insulin resistance (HOMA-IR) index, and the immunoreactive insulin (IRI)/glucose index were found in the PCOS group than in the control group. Notably, the concentration of apelin was over five times lower in the PCOS group than in the control group. In patients with PCOS, a positive correlation was found between the concentrations of insulin and leptin and concentrations of leptin and IRI/glucose. Patients of the PCOS group with body mass index (BMI) ≥ 25 had significantly higher values of leptin, insulin, HOMA-IR index, and IRI/glucose index than patients of the PCOS group with normal BMI. In the PCOS group, a positive correlation was found between BMI and leptin concentration (r = 0.7176; p < 0.0001) and carbohydrate metabolism, such as insulin (r = 0.5524; p = 0.0003), glucose (r = 0.3843; p = 0.0157), HOMA-IR (r = 0.5895; p < 0.0001), and IRI/glucose (r = 0.3872; p = 0.0163). These findings were not observed in the control group. Conclusions: (1) Increased leptin concentration observed in women diagnosed de novo with PCOS as well as positive correlations between leptin and HOMA-IR, and IRI/glucose and BMI may indicate a potential role of leptin in the reduction of tissue sensitivity to insulin. (2) Significantly lower apelin concentration in the PCOS group (>5 fold) than in the control group, associated with a concomitant increase in leptin, may also contribute to carbohydrate metabolism disorders occurring in the course of PCOS.

11 March 2021 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
JFJan Filipiak
Jan Filipiak
JBJoanna Boinska
Joanna Boinska
KZKatarzyna Ziołkowska
Katarzyna Ziołkowska
MZMagdalena Zduńska
Magdalena Zduńska
EZElżbieta Zarychta
Elżbieta Zarychta
DRDanuta Rość
Danuta Rość
Recently, there is great interest in vasculogenesis, a process of the formation of new blood vessels from progenitor cells or angioblasts, in the pathogenesis of cancer. To the best of our knowledge, the evaluation of endothelial progenitor cells (EPCs) in Hodgkin's lymphoma has not yet been reported. The aim of the present study was to assess the number of EPCs and selected cytokines, such as vascular endothelial growth factor (VEGF-A) and stromal cell-derived factor (SDF-1α) involved in vasculogenesis in Hodgkin's lymphoma patients. The study was conducted in a group of 42 patients with Hodgkin's lymphoma (eight patients with relapsed Hodgkin's lymphoma and 34 patients before the first treatment) and 30 healthy controls. The number of EPCs defined as CD31(+), CD34(+), CD45(−), CD133(+) was analysed on FacsCalibur flow cytometer and the concentration of VEGF-A and SDF-1α was assessed by ELISA. The study showed that there was a significantly higher EPCs number and VEGF-A concentration in the blood of Hodgkin's lymphoma patients compared to healthy individuals (8.20 vs. 0.55 cells/μl; P < 0.000001; 85.10 vs. 25.33 pg/ml, P = 0.000017; respectively). Detailed analysis revealed that there was elevated EPCs number in both study subgroups as compared to the control group. However, there was no difference in VEGF concentration between recurrent Hodgkin's lymphoma patients and the control group. A significant positive correlation was found between the number of EPCs and VEGF-A concentration (R = 0.31, P = 0.047). Significantly higher EPCs number combined with increased VEGF-A concentration, found in Hodgkin's lymphoma patients before the first treatment, suggest stimulation of new blood vessels formation, which may in turn contribute to tumour growth and metastasis in these patients.

Verified
Journal Article
Open access
PDF file
AWAdam Wiśniewski
Adam Wiśniewski
JBJoanna Boinska
Joanna Boinska
KZKatarzyna Ziołkowska
Katarzyna Ziołkowska
ALAdam Lemanowicz
Adam Lemanowicz
Karolina Filipska-BlejderKarolina Filipska-Blejder
Karolina Filipska-Blejder
GKGrzegorz M. Kozera
Grzegorz M. Kozera
Background: The aim of the study was to assess the number of endothelial progenitor cells (EPCs) in patients with acute stroke due to cerebral microangiopathy and evaluate whether there is a relationship between their number and clinical status, radiological findings, risk factors, selected biochemical parameters, and prognosis, both in ischemic and hemorrhagic stroke. Methods: In total, 66 patients with lacunar ischemic stroke, 38 patients with typical location hemorrhagic stroke, and 22 subjects from the control group without acute cerebrovascular incidents were included in the prospective observational study. The number of EPCs was determined in serum on the first and eighth day after stroke onset using flow cytometry and identified with the immune-phenotype classification determinant (CD)45−, CD34+, CD133+. Results: We demonstrated a significantly higher number of EPCs on the first day of stroke compared to the control group (med. 17.75 cells/µL (0–488 cells/µL) vs. 5.24 cells/µL (0–95 cells/µL); p = 0.0006). We did not find a relationship between the number of EPCs in the acute phase of stroke and the biochemical parameters, vascular risk factors, or clinical condition. In females, the higher number of EPCs on the first day of stroke is related to a favorable functional outcome on the eighth day after the stroke onset compared to males (p = 0.0355). We found that a higher volume of the hemorrhagic focus on the first day was correlated with a lower number of EPCs on the first day (correlation coefficient (R) = −0.3378, p = 0.0471), and a higher number of EPCs on the first day of the hemorrhagic stroke was correlated with a lower degree of regression of the hemorrhagic focus (R = −0.3896, p = 0.0367). Conclusion: The study showed that endothelial progenitor cells are an early marker in acute microangiopathy-associated stroke regardless of etiology and may affect the radiological findings in hemorrhagic stroke. Nevertheless, their prognostic value remains doubtful in stroke patients.

30 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JBJoanna Boinska
Joanna Boinska
MKMarek Koziński
Marek Koziński
MKMichal Kasprzak
Michal Kasprzak
MZMichał Ziołkowski
Michał Ziołkowski
JKJacek Kubica
Jacek Kubica
DRDanuta Rość
Danuta Rość
There is limited information about diurnal changes in fibrinolysis parameters after acute myocardial infarction (AMI) and their relationship with on-treatment platelet reactivity. The aim of this study was to assess tissue plasminogen activator (t-PA), plasminogen activator inhibitor type-1 (PAI-1), α2-antiplasmin (α2-AP) activity, and plasmin–antiplasmin (PAP) complexes in 30 AMI patients taking dual antiplatelet therapy (DAPT), i.e., acetylsalicylic acid and clopidogrel. Fibrinolytic parameters were assessed at four time points (6 a.m., 10 a.m., 2 p.m., and 7 p.m.) on the third day after AMI using immunoenzymatic methods. Moreover, platelet reactivity was measured using multiple-electrode aggregometry, to assess potential differences in fibrinolytic parameters in low/high on-aspirin platelet reactivity and low/high on-clopidogrel platelet reactivity subgroups of patients. We detected significant diurnal oscillations in t-PA and PAI-1 levels in the whole study group. However, PAP complexes and α2-AP activity were similar at the analyzed time points. Our study reveals a potential impact of DAPT on the time course of fibrinolytic parameters, especially regarding clopidogrel. We suggest the presence of diurnal variations in t-PA and PAI-1 concentrations in AMI patients, with the highest levels midmorning, regardless of platelet reactivity. Significantly elevated levels of PAI-1 during the evening hours in clopidogrel-resistant patients may increase the risk of thrombosis.

Verified
Journal Article
Open access
PDF file
JBJoanna Boinska
Joanna Boinska
Artur SłomkaArtur Słomka
Artur Słomka
MSMagdalena Sury
Magdalena Sury
MWMałgorzata Wiszniewska
Małgorzata Wiszniewska
EPEwa Pisarek
Ewa Pisarek
EŻEwa Żekanowska
Ewa Żekanowska
The hemojuvelin–hepcidin regulatory axis may play a key role in the iron metabolism both systemically and locally. There is a pressing need to evaluate this tightly regulated network of iron parameters and their potential impact on the development of ischemic stroke (IS). We aimed to assess iron metabolism biomarkers in patients after IS, evaluating changes over time and considering their clinical features. We studied 45 patients diagnosed with IS. We assessed major iron metabolism parameters, such as hepcidin, soluble hemojuvelin (sHJV), soluble transferrin receptor (sTfR), and ferritin, using immunoenzymathic methods at two time points: on admission and on the 7th day post IS. We found increased ferritin levels on the 7th day post IS compared to admission, and this was observed in the entire study group (p = 0.03) and in the subgroup treated with thrombolysis (p = 0.02). The hepcidin levels, on the other hand, showed a significant decrease on the 7th day, though this difference was only evident in the entire study group (p = 0.04). We also discovered significantly elevated sHJV levels in patients with PACI stroke compared to other stroke locations, both on admission and on the 7th day post IS (p < 0.05). Significantly higher sHJV levels were observed in patients treated with thrombolysis compared to those receiving conventional treatment, regardless of the time point (p < 0.0001 and p = 0.0002, respectively). Our study revealed changes in the iron metabolism parameters during stroke. The patients with anterior cerebral infarction and those treated with thrombolysis presented significantly elevated sHJV levels.

Verified
Journal Article
Open access
PDF file
WKWojciech Kupczyk
Wojciech Kupczyk
JBJoanna Boinska
Joanna Boinska
Artur SłomkaArtur Słomka
Artur Słomka
KKKinga Kupczyk
Kinga Kupczyk
MJMarek Jackowski
Marek Jackowski
EŻEwa Żekanowska
Ewa Żekanowska
Obesity and bariatric surgery are both associated with disrupted iron homeostasis. These alterations may be mediated by newly identified iron metabolism regulators. The aim of this study was to conduct a short-term, detailed analysis of hepcidin, soluble hemojuvelin, ferroportin, and erythroferrone—as well as whole-body composition—before and five months after sleeve gastrectomy. This approach may help elucidate the potential impact of bariatric surgery on iron metabolism and the timing of these changes. The study included 40 obese patients aged 26–64 eligible for laparoscopic sleeve gastrectomy. Iron parameters were assessed with immunoenzymatic methods. We found significantly increased iron levels (79 µg/dL vs. 95 µg/dL, p = 0.0016) as well as reduced hepcidin concentrations five months after bariatric surgery (54.46 ng/mL vs. 33.88 ng/mL, p = 0.0177). The change in the reduction in mean body fat (delta MBF) and body fat percentage (delta BPF) was positively associated with delta hepcidin levels with correlation coefficients of R = 0.36 (p = 0.0228) for MBF and R = 0.42 (p = 0.0070) for BPF. Moreover, significant correlations were observed between the reduction in body fat and soluble hemojuvelin (R = 0.31 p = 0.0489 for MBF) (R = 0.45 p = 0.0032 for PBF). No patient showed laboratory signs of iron deficiency. Decreased serum hepcidin levels observed five months after sleeve gastrectomy are associated with improved iron status, as indicated by increased serum iron and red blood cell indices. Positive correlations between body fat reduction and both hepcidin and soluble hemojuvelin levels suggest that the resolution of adipose tissue-related inflammation may contribute to improved iron bioavailability.